Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;126(12):1571-1583.
doi: 10.1007/s11547-021-01436-7. Epub 2021 Dec 4.

Delta radiomics: a systematic review

Valerio Nardone  1 , Alfonso Reginelli  2 , Roberta Grassi  1 , Luca Boldrini  3 , Giovanna Vacca  1 , Emma D'Ippolito  1 , Salvatore Annunziata  3 , Alessandra Farchione  3 , Maria Paola Belfiore  1 , Isacco Desideri  4 , Salvatore Cappabianca  1
Affiliations

Delta radiomics: a systematic review

Valerio Nardone et al. Radiol Med. 2021 Dec.

Abstract

Background: Radiomics can provide quantitative features from medical imaging that can be correlated with various biological features and clinical endpoints. Delta radiomics, on the other hand, consists in the analysis of feature variation at different acquisition time points, usually before and after therapy. The aim of this study was to provide a systematic review of the different delta radiomics approaches.

Methods: Eligible articles were searched in Embase, PubMed, and ScienceDirect using a search string that included free text and/or Medical Subject Headings (MeSH) with three key search terms: "radiomics", "texture", and "delta". Studies were analysed using QUADAS-2 and the RQS tool.

Results: Forty-eight studies were finally included. The studies were divided into preclinical/methodological (five studies, 10.4%); rectal cancer (six studies, 12.5%); lung cancer (twelve studies, 25%); sarcoma (five studies, 10.4%); prostate cancer (three studies, 6.3%), head and neck cancer (six studies, 12.5%); gastrointestinal malignancies excluding rectum (seven studies, 14.6%), and other disease sites (four studies, 8.3%). The median RQS of all studies was 25% (mean 21% ± 12%), with 13 studies (30.2%) achieving a quality score < 10% and 22 studies (51.2%) < 25%.

Conclusions: Delta radiomics shows potential benefit for several clinical endpoints in oncology (differential diagnosis, prognosis and prediction of treatment response, and evaluation of side effects). Nevertheless, the studies included in this systematic review suffer from the bias of overall low quality, so that the conclusions are currently heterogeneous, not robust, and not replicable. Further research with prospective and multicentre studies is needed for the clinical validation of delta radiomics approaches.

Keywords: Delta radiomics; Meta-analysis; Oncology; Precision medicine; Radiomics; Radiotherapy; Texture analysis.

PubMed Disclaimer

References

    1. Bodalal Z, Trebeschi S, Beets-Tan R (2018) Radiomics: a critical step towards integrated healthcare. Insights Imaging 9(6):911–914. https://doi.org/10.1007/s13244-018-0669-3 - DOI - PubMed - PMC
    1. Ciolina M, Vinci V, Villani L, Gigli S, Saldari M, Panici PB, Perniola G, Laghi A, Catalano C, Manganaro L (2019) Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix. Radiol Med 124(10):955–964. https://doi.org/10.1007/s11547-019-01055-3 - DOI - PubMed
    1. Nardone V, Tini P, Croci S, Carbone SF, Sebaste L, Carfagno T, Battaglia G, Pastina P, Rubino G, Mazzei MA, Pirtoli L (2018) 3D bone texture analysis as a potential predictor of radiation-induced insufficiency fractures. Quant Imaging Med Surg 8(1):14–24. https://doi.org/10.21037/qims.2018.02.01 - DOI - PubMed - PMC
    1. De Piano F, Buscarino V, Maresca D, Maisonneuve P, Aletti G, Lazzari R, Vavassori A, Bellomi M, Rizzo S (2019) Do DWI and quantitative DCE perfusion MR have a prognostic value in high-grade serous ovarian cancer? Cancers (Basel) 124(12):1315–1323. https://doi.org/10.1007/s11547-019-01075-z - DOI
    1. Crombé A, Kind M, Ray-Coquard I, Isambert N, Chevreau C, André T, Lebbe C, Cesne AL, Bompas E, Piperno-Neumann S, Saada E, Bouhamama A, Blay JY, Italiano A (2020) Progressive desmoid tumor: radiomics compared with conventional response criteria for predicting progression during systemic therapy-A multicenter study by the french sarcoma group. AJR Am J Roentgenol 215(6):1539–1548. https://doi.org/10.2214/ajr.19.22635 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources